Literature DB >> 28346804

Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.

Sana Mansha1, Muhammad Imran2, Amir Miraj Ul Hussain Shah2, Muhsin Jamal3, Fayyaz Ahmed2, Muhammad Atif2, Muhammmad Saleem2, Sher Zaman Safi4, Zareen Fatima5, Ahmed Bilal Waqar2.   

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the major cause of the global burden of hepatitis. One of the main routes of transmission for both viruses is through exposure to infected blood, which includes sharing blood-contaminated syringes and needles. Human immunodeficiency virus (HIV) attacks the immune system and results in acquired immune deficiency syndrome and opportunistic infections. The objective of this study was to assess the epidemiology of HBV and HCV infections among HIV-infected people who inject drugs (PWID). The study enrolled 100 PWID from different addiction centers of the city of Lahore in Pakistan. All subjects were HIV-infected males and were above 16 years of age. Screening of HBV and HCV infections was performed through immunochromatography tests and enzyme-linked immunosorbent assays. The prevalence of HCV and HBV infections among the 100 HIV-infected PWID was 55% and 6%, respectively. HIV monoinfection was found in 37% of the subjects, while triple infection was detected in 2% of the subjects. Majority of the HIV-infected PWID were using heroin and Avil injections (65%). Half of the subjects had used injection drugs for 1-5 years, while 32% had used injection drugs for 6-10 years. HCV infection was more common than HBV infection among the enrolled subjects. Most of the PWID were practicing heroin and Avil injections.

Entities:  

Keywords:  HBV; HCV; HIV; PWID; infection; injection

Mesh:

Year:  2017        PMID: 28346804     DOI: 10.1089/vim.2016.0144

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  5 in total

Review 1.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Authors:  Kasha P Singh; Megan Crane; Jennifer Audsley; Anchalee Avihingsanon; Joe Sasadeusz; Sharon R Lewin
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

2.  Hepatitis C virus transmission cluster among injection drug users in Pakistan.

Authors:  Kashif Iqbal Sahibzada; Lilia Ganova-Raeva; Zoya Dimitrova; Sumathi Ramachandran; Yulin Lin; Garrett Longmire; Leonard Arthur; Guo-Liang Xia; Yury Khudyakov; Idrees Khan; Saima Sadaf
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

3.  Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.

Authors:  Lucy Platt; Clare E French; Catherine R McGowan; Keith Sabin; Erin Gower; Adam Trickey; Bethan McDonald; Jason Ong; Jack Stone; Philippa Easterbrook; Peter Vickerman
Journal:  J Viral Hepat       Date:  2019-12-22       Impact factor: 3.728

4.  Exposure to aflatoxin B1 and associated risk factors in hepatitis C patients in cosmopolitan city of Pakistan: facility-based study.

Authors:  Muhammad Ayaz Mustufa; Zubia Zia; Rabia Ilyas; Rehan Khan; Syed Naim Ul Hasan Naqvi; Firdous Imran Ali
Journal:  Pan Afr Med J       Date:  2021-12-21

5.  The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.

Authors:  Sarwat Mahmud; Ghina R Mumtaz; Hiam Chemaitelly; Zaina Al Kanaani; Silva P Kouyoumjian; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Addiction       Date:  2020-02-03       Impact factor: 6.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.